2023 Will Be a Big Year for U.S. Healthcare M&A

Today we're looking at the biggest trends in U.S. Healthcare M&A as discussed at the recently held J.P. Morgan Healthcare Conference.

“We can expect this to be a big year for M&A for Pharmaceutical and medical device companies,” says our guest Rebecca Wenzel, a senior reporter for Mergermarket. “They are sitting on piles of cash that they’re ready to deploy, though one of the differences we’ll see is that they’re going to be more selective about their roster of assets and assets will be met with more due diligence.”

Listen to learn about:

• The rise of bolt-on deals in Biopharma and medical devices
• Expected wave of Healthcare IT deals at reset valuations
• Consolidation in private practice management
• How financing challenges are affecting deals

Dealcast is presented by Mergermarket and SS&C Intralinks.